WHO ICTRP trial
Single-arm clinical study of PD-1Ab21-BCMACAR-T cells (CD003) in the treatment…
ChiCTR2300078977 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300078977 |
|---|---|
| Public title | Single-arm clinical study of PD-1Ab21-BCMACAR-T cells (CD003) in the treatment of refractory and relapsed multiple myeloma |
| Scientific title | Single-arm clinical study of PD-1Ab21-BCMACAR-T cells (CD003) in the treatment of refractory and relapsed multiple myeloma |
| Primary sponsor | Chinese People's Liberation Army (PLA) General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Refractory and relapsed multiple myeloma |
| Interventions | Treatment group:CAR-T cell infusion therapy |
| Registration date | Dec 22, 2023 |
| Target size | Treatment group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: